Comparison between the effects of Micrococcus, BCG and related polysaccharides in preclinical chemo-immunotherapy of murine L 1210 leukaemia [proceedings].
作者信息
Verloes R, Atassi G, Dumont P, Kanarek L
出版信息
Arch Int Physiol Biochim. 1978 Oct;86(4):969-71.
PMID:84653
Abstract
摘要
相似文献
1
2
3
Successful immunotherapy with micrococcus, BCG or related polysaccharides on L1210 leukaemia after BCNU chemotherapy.在卡氮芥化疗后，用微球菌、卡介苗或相关多糖对L1210白血病进行成功的免疫治疗。
Br J Cancer. 1981 Feb;43(2):201-9. doi: 10.1038/bjc.1981.29.
4
Superiority of Micrococcus lysodeikticus to BCG in chemo-immunotherapy of advanced L1210 leukaemia.在晚期L1210白血病的化学免疫治疗中，溶壁微球菌相对于卡介苗的优越性。
Eur J Cancer Clin Oncol. 1981 Aug;17(8):849-56. doi: 10.1016/0014-2964(81)90304-2.
5
Influence of micrococcus, BCG and related polysaccharides on the proliferation of the L1210 leukaemia.微球菌、卡介苗及相关多糖对L1210白血病细胞增殖的影响。
Br J Cancer. 1978 Nov;38(5):599-605. doi: 10.1038/bjc.1978.255.
6
BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Natl Cancer Inst Monogr. 1973 Dec;39:165-75.
7
Active immunotherapy in spontaneous leukemia of AkR mice.对AkR小鼠自发性白血病的主动免疫疗法。
Exp Hematol. 1973;1(2):110-4.
8
[Immune manipulation of BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukemia].[环磷酰胺治疗L1210白血病的化学免疫疗法中，卡介苗在其之前或之后给药的免疫调控]
C R Acad Hebd Seances Acad Sci D. 1975 Apr 7;280(13):1623-6.
9
The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.全身免疫佐剂在癌症预防或治疗中的应用。
Johns Hopkins Med J Suppl. 1974;3:85-102.
Zotero 插件